Jen-Tsan A. Chi, Ph.D.

Stanford University, Palo Alto, CA 
Immunology, Molecular Biology
"Jen-Tsan Chi"
Mean distance: 9.53


Sign in to add mentor
Mark M. Davis grad student 2000 Stanford
 (The mechanism of Blimp -1 in B cell terminal differentiation.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang WH, Chi JT. (2020) Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis. Molecular & Cellular Oncology. 7: 1699375
Lin CC, Mabe NW, Lin YT, et al. (2020) RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence. Cell Death and Differentiation
Chen PH, Hu J, Wu J, et al. (2020) Gigaxonin glycosylation regulates intermediate filament turnover and may impact giant axonal neuropathy etiology or treatment Jci Insight. 5
Huynh DT, Chen P, Hu J, et al. (2020) Kelch‐like Proteins Have A Sweet Spot: Site‐specific Glycosylation Influences Metabolic Regulation and Protein Homeostasis The Faseb Journal. 34: 1-1
Sun T, Chi J. (2020) Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications Genes and Diseases
Walzer KA, Fradin H, Emerson LY, et al. (2019) Latent transcriptional variations of individual Plasmodium falciparum uncovered by single-cell RNA-seq and fluorescence imaging. Plos Genetics. 15: e1008506
Yang WH, Huang Z, Wu J, et al. (2019) A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer. Molecular Cancer Research : McR
Yang WH, Ding CC, Sun T, et al. (2019) The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. Cell Reports. 28: 2501-2508.e4
Chen PH, Wu J, Ding CC, et al. (2019) Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death and Differentiation
Macias E, Cho J, Rosowicz D, et al. (2019) Abstract 3590: Mechanisms and inhibition RIOK2 for obesity-driven prostate cancer Cancer Research
See more...